Acute Pulmonary Embolism Clinical Trial
Official title:
Prospective Study for the Outpatient Treatment of Patients With Very Low Risk Acute Symptomatic Pulmonary Embolism. TRAMTEP Study.
Objectives: To evaluate the safety of outpatient treatment of patients with very low-risk pulmonary embolism (PE), and the satisfaction and quality of life of this management. Methods: An experimental study of routine clinical practice will be carried out in which 300 consecutive hemodynamically stable patients with acute symptomatic PE will be included, who meet all the inclusion criteria and none of the exclusion criteria. All patients included in the study will be treated on an outpatient basis, that is, they will be discharged within the first 24 hours of the diagnosis of PE in the Emergency Department. The Computerized Registry of Thromboembolic Disease RIETE (Registro Informatizado de Enfermedad TromboEmbólica) will be used to collect the data in electronic case report form (CRF) and ensure the quality of the data. Setting: Emergency, Pneumology and Internal Medicine Services of 10 Spanish hospitals. Analysis: An intention-to-treat (ITT) analysis will be performed on all patients who sign the informed consent and are included in the study (regardless of whether or not they receive the assigned strategy). Additionally, an analysis of all patients who are treated on an outpatient basis without deviations or violations of the protocol will be performed. The primary outcome considered will be the composite of recurrent PE, major bleeding, or death from any cause during the first 30 days after enrollment in the study. Patient satisfaction and quality of life will be considered as secondary outcomes.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00519506 -
A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli
|
Phase 2 | |
Not yet recruiting |
NCT04110275 -
Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)
|
Phase 2 | |
Completed |
NCT05318092 -
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
|
N/A | |
Not yet recruiting |
NCT05792397 -
TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study)
|
N/A | |
Completed |
NCT01604538 -
Italian Pulmonary Embolism Registry - IPER
|
N/A | |
Completed |
NCT03631810 -
Contemporary Clinical Management Of Acute Pulmonary Embolism
|
||
Recruiting |
NCT03504007 -
Registry of Patients Prescribed Anticoagulation
|
||
Completed |
NCT01513759 -
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
|
Phase 3 | |
Completed |
NCT03108833 -
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
|
Phase 2 | |
Completed |
NCT04037423 -
European Database on Catheter-directed Treatment of Pulmonary Embolism.
|
||
Not yet recruiting |
NCT06189313 -
CLEANer Aspiration for Pulmonary Embolism
|
N/A | |
Not yet recruiting |
NCT05469724 -
Clinical Pulmonary Embolism
|
||
Completed |
NCT01014156 -
Epoprostenol in Pulmonary Embolism
|
Phase 4 | |
Recruiting |
NCT06038630 -
129Xe MRI Cardiopulmonary
|
Phase 2 | |
Recruiting |
NCT06192199 -
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
|
||
Recruiting |
NCT04757129 -
Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
|
||
Completed |
NCT03966079 -
Thrombolysis Endovascular Treatment of Pulmonary Embolism
|
Phase 3 | |
Recruiting |
NCT03916302 -
Pulmonary Embolism WArsaw REgistry
|
||
Recruiting |
NCT06062329 -
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
|
N/A | |
Not yet recruiting |
NCT04480892 -
Fibrinolytic Deficit in Patients With Acute PE
|